Cargando…

Current Research and Development of Chemotherapeutic Agents for Melanoma

Cutaneous malignant melanoma is the most lethal form of skin cancer and an increasingly common disease worldwide. It remains one of the most treatment-refractory malignancies. The current treatment options for patients with metastatic melanoma are limited and in most cases non-curative. This review...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsan, Kyaw Minn, Chen, Chun-Chieh, Shyur, Lie-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835084/
https://www.ncbi.nlm.nih.gov/pubmed/24281076
http://dx.doi.org/10.3390/cancers2020397
_version_ 1782292096868155392
author Hsan, Kyaw Minn
Chen, Chun-Chieh
Shyur, Lie-Fen
author_facet Hsan, Kyaw Minn
Chen, Chun-Chieh
Shyur, Lie-Fen
author_sort Hsan, Kyaw Minn
collection PubMed
description Cutaneous malignant melanoma is the most lethal form of skin cancer and an increasingly common disease worldwide. It remains one of the most treatment-refractory malignancies. The current treatment options for patients with metastatic melanoma are limited and in most cases non-curative. This review focuses on conventional chemotherapeutic drugs for melanoma treatment, by a single or combinational agent approach, but also summarizes some potential novel phytoagents discovered from dietary vegetables or traditional herbal medicines as alternative options or future medicine for melanoma prevention. We explore the mode of actions of these natural phytoagents against metastatic melanoma.
format Online
Article
Text
id pubmed-3835084
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Diversity Preservation International
record_format MEDLINE/PubMed
spelling pubmed-38350842013-11-21 Current Research and Development of Chemotherapeutic Agents for Melanoma Hsan, Kyaw Minn Chen, Chun-Chieh Shyur, Lie-Fen Cancers (Basel) Review Cutaneous malignant melanoma is the most lethal form of skin cancer and an increasingly common disease worldwide. It remains one of the most treatment-refractory malignancies. The current treatment options for patients with metastatic melanoma are limited and in most cases non-curative. This review focuses on conventional chemotherapeutic drugs for melanoma treatment, by a single or combinational agent approach, but also summarizes some potential novel phytoagents discovered from dietary vegetables or traditional herbal medicines as alternative options or future medicine for melanoma prevention. We explore the mode of actions of these natural phytoagents against metastatic melanoma. Molecular Diversity Preservation International 2010-04-09 /pmc/articles/PMC3835084/ /pubmed/24281076 http://dx.doi.org/10.3390/cancers2020397 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Hsan, Kyaw Minn
Chen, Chun-Chieh
Shyur, Lie-Fen
Current Research and Development of Chemotherapeutic Agents for Melanoma
title Current Research and Development of Chemotherapeutic Agents for Melanoma
title_full Current Research and Development of Chemotherapeutic Agents for Melanoma
title_fullStr Current Research and Development of Chemotherapeutic Agents for Melanoma
title_full_unstemmed Current Research and Development of Chemotherapeutic Agents for Melanoma
title_short Current Research and Development of Chemotherapeutic Agents for Melanoma
title_sort current research and development of chemotherapeutic agents for melanoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835084/
https://www.ncbi.nlm.nih.gov/pubmed/24281076
http://dx.doi.org/10.3390/cancers2020397
work_keys_str_mv AT hsankyawminn currentresearchanddevelopmentofchemotherapeuticagentsformelanoma
AT chenchunchieh currentresearchanddevelopmentofchemotherapeuticagentsformelanoma
AT shyurliefen currentresearchanddevelopmentofchemotherapeuticagentsformelanoma